Retrospective analysis of adverse events with systemic onychomycosis medications reported to the United States Food and Drug Administration

Pharmacotherapy for onychomycosis: new and emerging treatments

(2019) Shari R. Lipner   EXPERT OPINION ON PHARMACOTHERAPY

Part II: Onychomycosis: Treatment and Prevention of Recurrence

(2018) Shari R. Lipner et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Part I: Onychomycosis: Clinical Overview and Diagnosis

(2018) Shari R. Lipner et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Onychomycosis in children: Safety and efficacy of antifungal agents

(2018) Aditya K. Gupta et al.   PEDIATRIC DERMATOLOGY

Utility of Laboratory Test Result Monitoring in Patients Taking Oral Terbinafine or Griseofulvin for Dermatophyte Infections

(2018) Deirdre A. Stolmeier et al.   JAMA Dermatology

Laboratory Monitoring During Systemic Terbinafine Therapy for Pediatric Onychomycosis

(2017) Deepa Patel et al.   JAMA Dermatology